載入...
In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emanating human infectious coronavirus that causes COVID-19 disease. On 11th March 2020, it has been announced as a pandemic by the World Health Organization (WHO). Recently, several repositioned drugs have been subjected to...
Na minha lista:
| 發表在: | Protein J |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer US
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7776322/ https://ncbi.nlm.nih.gov/pubmed/33387249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10930-020-09945-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|